Prometheus Biosciences, Inc. (RXDX) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 4 Buy, 7 Hold.
The consensus price target is $138.57 (low: $67.00, high: $200.00), representing a downside of 30.7% from the current price $199.92.
RXDX Stock — 12-Month Price Forecast
$138.57
▼ -30.69% Downside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for Prometheus Biosciences, Inc., the average price target is $138.57, with a high forecast of $200.00, and a low forecast of $67.00.
The average price target represents a -30.69% change from the last price of $199.92.
Highest Price Target
$200.00
Average Price Target
$138.57
Lowest Price Target
$67.00
RXDX Analyst Ratings
Hold
Based on 11 analysts giving stock ratings to Prometheus Biosciences, Inc. in the past 3 months
